HAVCR2 and neoplasm: Moreover, tumor cells or tumor-infiltrating lymphocytes can express suppressive immune checkpoints, including PD-1/PD-L1, TIGIT, LAG-3, and TIM-3 to attenuate anti-tumor immunity82, 83, 84, 85.